日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Zinc Deficiency Among Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

炎症性肠病患者锌缺乏症:系统评价和荟萃分析

Mohammed Abdul, Rahman Hameed; Reyaz, Nafisa; Yigzaw, Abebe; Mohammed, Bilal Asad; Hussaini, Helai; Amin, Adil; Rauf, Mohammed Qasim; Ali, Neelum

Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy

PVTX-405 的开发旨在将其作为一种高效且高选择性的 IKZF2 分子胶降解剂用于癌症免疫治疗。

Zhixiang Chen # ,Harshil Dhruv # ,Xuqing Zhang # ,Rohan Kalyan Rej # ,Longchuan Bai # ,Donna McEachern ,Paul Kirchhoff ,Rakesh Nagilla ,Larry J Jolivette ,Cory T Rice ,Peter Orth ,Corey O Strickland ,E Scott Priestley ,Helai P Mohammad ,Meilin Wang ,Bo Wen ,Duxin Sun ,Zhihua Sui ,Shaomeng Wang

SAT-122 The Role of Targeted Plasma Proteomics for Identifying Inflammatory Signatures Associated with Risk for Perinatal Depression

SAT-122 靶向血浆蛋白质组学在识别与围产期抑郁症风险相关的炎症特征中的作用

Xia, Ke; Manning, Marta; Hesham, Helai; Lin, Qishan; Bystroff, Christopher; Colón, Wilfredo; Braybrook, Emma; Natasha, Khovanova; Grammatopoulos, Dimitris; Braybrook, Emma; Natasha, Khovanova; Grammatopoulos, Dimitris

Model interpretability on private-safe oriented student dropout prediction

模型对以隐私安全为导向的学生辍学预测的可解释性

Liu, Helai; Mao, Mao; Li, Xia; Gao, Jia

Mavorixafor, CXCR4 antagonist, a novel treatment for WHIM syndrome, first FDA approval 2024

Mavorixafor,一种CXCR4拮抗剂,是治疗WHIM综合征的新疗法,预计将于2024年获得FDA首次批准。

Waheed, Aiman; Gul, Muhammad Hamza; Ilmaguook, Badr; Wardak, Abdul Baseer; Sadeed, Fnu; Hussaini, Helai; Ahmad, Sarah

FDA approves Resmetirom: groundbreaking treatment for NASH liver scarring in moderate to advanced fibrosis

FDA批准Resmetirom:治疗中度至重度纤维化NASH肝瘢痕的突破性疗法

Waheed, Aiman; Gul, Muhammad H; Shabbir, Muhammad U B; Raja, Hafsa A A; Wardak, Abdul B; Hussaini, Helai; Shah, Yash

Elafibranor: a breakthrough therapy revolutionizing primary biliary cholangitis (PBC) treatment

Elafibranor:一项突破性疗法,彻底改变原发性胆汁性胆管炎 (PBC) 的治疗

Gul, Muhammad H; Waheed, Aiman; Wardak, Abdul B; Shah, Yash; Azam Raja, Hafsa A; Ilmaguook, Badr; Hussaini, Helai; Zafar, Fatima

Crovalimab: a new era in paroxysmal nocturnal hemoglobinuria management

Crovalimab:阵发性睡眠性血红蛋白尿症治疗的新纪元

Waheed, Aiman; Gul, Muhammad Hamza; Wardak, Abdul Baseer; Shabbir, Muhammad Usama Bin; Touseef, Sabahat; Zafar, Fatima; Hussaini, Helai

Comparative Efficacy and Safety of Tegoprazan Versus Proton Pump Inhibitors for Erosive Esophagitis: A Systematic Review and Meta-Analysis

替戈拉赞与质子泵抑制剂治疗糜烂性食管炎的疗效和安全性比较:系统评价和荟萃分析

Hussaini, Helai; Kebede, Tamiru M; Afework, Tekleweyn S; Kumari, Deepa; Fadeyi, Olaniyi; Chaudhari, Sandipkumar S; Habib, Ihtisham; Hirani, Shamsha

Acute Liver Injury Following Herbal Drink Consumption With Steatosis and Immune Activation: A Case Report

饮用草药饮料后发生急性肝损伤伴脂肪变性和免疫激活:病例报告

Hussaini, Helai; Waheed, Aiman; Fadeyi, Olaniyi; Boostany, Tony; Hashimoto, Yusuke; Flint, Andrew T